VST BIO Corp
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $31.9Mattributed |
|---|---|
| Latest round | Funding round, $31.9M, 2026-04-24attributed |
| Founded | unknown |
| Headquarters | SAN DIEGO, CA |
| Industry | bio |
| Stage | unknown |
| Website | vstbio.com |
VST Bio is a biotechnology company developing therapeutics aimed at modulating the immune system to treat inflammatory and immune-related disease. It is oriented toward patients and clinical partners in immunology and inflammation. Its work centers on a targeted mechanism for immune dysregulation that broad drugs do not selectively reach.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-24 | Funding round | $31.9M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $31.9M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $31.9M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | vstbio.com, read 2026-05-08 |
| Description | self-reported | vstbio.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $31.9M, 2026-04-24 → Funding round, $31.9M, 2026-04-24, sec-edgar, No document URL on file | Latest round | seed, $31.9M, 2026-04-24 → Funding round, $31.9M, 2026-04-24 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes